Former Chief Financial Officer · Cullinan Therapeutics, Inc. (CGEM)

Jeffrey Trigilio

A named executive officer of Cullinan Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$4,002,434

Salary $123,396Stock awards $1,498,687Bonus $49,359

FY2023: $2,204,333

3rd of 4 named executive officers at Cullinan Therapeutics by FY2024 total.

4 named officers on file for Cullinan Therapeutics, FY2024

Jeffrey Trigilio’s pay file — $29

  • 5 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cullinan Therapeutics’s whole pay program stands against its peers

  • Cullinan Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CGEM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Jeffrey Trigilio’s full pay file as a PDF — free

More than this page: up to 10 years of Jeffrey’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Jeffrey Trigilio compensation by year

Cullinan Therapeutics Summary Compensation Table · all 5 fiscal years held
In US dollars, as Cullinan Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022FY2023FY2024
Salary$118,029$400,000$452,000$474,600$123,396
Bonus$53,168$220,000$260,352$404,811$49,359
Stock awards$0$0$510,000$532,980$1,498,687
Option awards$1,566,488$2,032,777$686,250$748,739$1,769,799
Non-equity incentive$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0
All other—$14,500$15,634$43,203$561,193
Total$1,737,685$2,667,277$1,924,236$2,204,333$4,002,434

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cullinan Therapeutics, Inc. DEF 14A filed April 25, 2025, accession 0000950170-25-058316, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cullinan Therapeutics, Inc. filed document, accession 0000950170-25-058316. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

$1.7M
$2.7M
$1.9M
$2.2M
$4.0M
FY20
FY21
FY22
FY23
FY24
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU37,209$379,160—
RSU20,313$206,989—
Option39,722—$21.00
Option74,021—$11.34
Option47,418—$4.30
Option40,625—$13.60

Per the Outstanding Equity Awards at Fiscal Year-End table in Cullinan Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Cullinan Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Nadim AhmedPresident and Chief Executive Officer$7,684,366
Mary Kay FentonChief Financial Officer$4,142,413
Jeffrey Trigilio · this pageFormer Chief Financial Officer$4,002,434
Jeffrey JonesChief Medical Officer$3,388,014

The full Cullinan Therapeutics compensation record

free company brief

This page is one person within Cullinan Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cullinan Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jeffrey Trigilio's compensation dossier · One-time report. No refunds.